1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine

BACKGROUND: Cell-mediated immunity (CMI) after anti-Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 vaccines has been poorly explored in recipients of allogeneic hematopoietic stem-cell transplantation (HSCT), especially with regard to the 3(rd) dose (booster). Aim of the study was to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Marco, Iannetta, Spalliera, Ilaria, Mallegni, Flavia, Mercante, Lisa, Imeneo, Alessandra, Crea, Angela, Lorenzo, Andrea Di, Campogiani, Laura, Malagnino, Vincenzo, Angelis, Gottardo De, Cerretti, Raffaella, Andreoni, Massimo, Sarmati, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752605/
http://dx.doi.org/10.1093/ofid/ofac492.1595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752605/
http://dx.doi.org/10.1093/ofid/ofac492.1595

Ejemplares similares